BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9637577)

  • 1. Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis.
    Contopoulos-Ioannidis DG; Ioannidis JP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):126-35. PubMed ID: 9637577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
    Garcia PM; Kalish LA; Pitt J; Minkoff H; Quinn TC; Burchett SK; Kornegay J; Jackson B; Moye J; Hanson C; Zorrilla C; Lew JF
    N Engl J Med; 1999 Aug; 341(6):394-402. PubMed ID: 10432324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.
    Ioannidis JP; Abrams EJ; Ammann A; Bulterys M; Goedert JJ; Gray L; Korber BT; Mayaux MJ; Mofenson LM; Newell ML; Shapiro DE; Teglas JP; Wilfert CM
    J Infect Dis; 2001 Feb; 183(4):539-45. PubMed ID: 11170978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Steketee RW; Pliner V; Bornschlegel K; Brown T; Orloff S; Matheson PB; Abrams EJ; Bamji M; Lambert G; Schoenbaum EA; Thomas PA; Heagarty M; Kalish ML
    AIDS; 1997 Mar; 11(4):437-44. PubMed ID: 9084790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.
    Cao Y; Krogstad P; Korber BT; Koup RA; Muldoon M; Macken C; Song JL; Jin Z; Zhao JQ; Clapp S; Chen IS; Ho DD; Ammann AJ
    Nat Med; 1997 May; 3(5):549-52. PubMed ID: 9142125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.
    O'Donovan D; Ariyoshi K; Milligan P; Ota M; Yamuah L; Sarge-Njie R; Whittle H
    AIDS; 2000 Mar; 14(4):441-8. PubMed ID: 10770548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.
    Leroy V; Montcho C; Manigart O; Van de Perre P; Dabis F; Msellati P; Meda N; You B; Simonon A; Rouzioux C;
    AIDS; 2001 Mar; 15(4):517-22. PubMed ID: 11242149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery.
    Coll O; Hernandez M; Boucher CA; Fortuny C; de Tejada BM; Canet Y; Caragol I; Tijnagel J; Bertran JM; Espanol T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):26-30. PubMed ID: 8989207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful prevention of hiv transmission from mother to infant in Brazil using a multidisciplinary team approach.
    Nogueira SA; Abreu T; Oliveira R; Araújo L; Costa T; Andrade M; Garcia Psic MF; Machado ; Rodrigues K; Mercadante R; Fernandes I; Sapia MC; Lambert JS
    Braz J Infect Dis; 2001 Apr; 5(2):78-86. PubMed ID: 11493413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Mock PA; Shaffer N; Bhadrakom C; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Roongpisuthipong A; Chinayon P; Kalish ML; Parekh B; Mastro TD
    AIDS; 1999 Feb; 13(3):407-14. PubMed ID: 10199232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
    Kakkar F; Lamarre V; Ducruet T; Boucher M; Valois S; Soudeyns H; Lapointe N
    BMC Infect Dis; 2014 May; 14():236. PubMed ID: 24885498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
    Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
    JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal HIV-1 DNA load and mother-to-child transmission.
    Arvold ND; Ngo-Giang-Huong N; McIntosh K; Suraseranivong V; Warachit B; Piyaworawong S; Changchit T; Lallemant M; Jourdain G;
    AIDS Patient Care STDS; 2007 Sep; 21(9):638-43. PubMed ID: 17919090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 viremia during the first 28 weeks of pregnancy is not associated with mother-to-child transmission.
    Senise JF; Palacios R; Tanno ZN; Lunardi L; Waghabi GR; Vaz MJ; Diaz RS; Castelo A
    Braz J Infect Dis; 2006 Aug; 10(4):259-63. PubMed ID: 17293908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.